We solve one problem, another one arises. Technology grows and adapts but so do bacteria and pathogens. Will we ever outrace illness? This debate considers our chances and the ethics of eradicating illness.
Pierre Meulin , IMI
Pierre Meulien is Executive Director of the Innovative Medicines Initiative (IMI), a €5 billion public-private partnership between the European Union and the European pharmaceutical industry. Previously, Dr Meulien was president and CEO of Genome Canada, a funder of genomics based research. Pierre Meulien was also the founding CEO of the Dublin Molecular Medicine Center in Ireland and has also worked in biotech and pharma industries. He has a Ph.D. from the University of Edinburgh.